Devotta A , Juraver-Geslin H , Gonzalez JA , Hong CS , Saint-Jeannet JP .

R01 DE014212 NIDCR NIH HHS, R01 DE025468 NIDCR NIH HHS

             neural crest cell development
             BMP signaling pathway
             face development

Xla Wt + sf3b4 MO (fig.4.c)
Xla Wt + sf3b4 MO (fig.4.e)
Xla Wt + sf3b4 MO (fig.5.a)
Xla Wt + sf3b4 MO (fig.5.a)
Xla Wt + sf3b4 MO (fig.6.c)
Xla Wt + sf3b4 MO (fig.7.d)
Xla Wt + sf3b4 MO (fig.7.d)
Xla Wt + sf3b4 MO (fig.7.d)
Xla Wt + sf3b4 MO (fig.7.f)
Xla Wt + sf3b4 MO (fig.7.h)
Xla Wt + sf3b4 MO (fig.8.a)

	Fig. 1. Sequence and structure comparison of Xenopus and Human SF3B4. The predicted amino acid sequences from Xenopus laevis and human, SF3B4 were aligned using ClustalW. The two RNA recognition motifs (RRM) are underlined.
	Fig. 2. Developmental expression of sf3b4. (A) RT-PCR analysis of sf3b4 developmental expression. The embryonic stages (St.) are according to Nieuwkoop and Faber (1967). Ornithine decarboxylase (odc) is shown as a loading control. (B) By whole-mount in situ hybridization sf3b4 is enriched dorsally at neurula stage (stage 13 and 15). At tailbud stage (stage 25 and 28) sf3b4 is detected in the branchial arches and the developing eyes. Dorsal views (d), anterior to top. Anterior views (a), dorsal to top. Lateral view, anterior to right, dorsal to top (stage 25 and 28).
	Fig. 3. Sf3b4MO, a translation blocking morpholino prevents snail2, sox10 and twist expression. (A) Design of the translation blocking morpholino antisense oligonucleotide. Sf3b4MO (red bar) targets the ATG start site of Xenopus Sf3b4 mRNA. (B) Western blot using lysates from embryos injected with XSf3b4 mRNA alone or in combination with Sf3b4MO, shows that Sf3b4MO blocks SF3B4 protein accumulation in vivo. α-tubulin is shown as a loading control. (C)Snail2 expression is reduced in Sf3b4MO-injected (40 ng) embryos (arrows). Dorsal views, anterior to top. The injected side (arrows) is indicated by the lineage tracer (Red-Gal). (D) The graph is a quantification of the results from three independent experiments. The number of embryos analyzed (n) is indicated on the top of the bar. (E) Gene expression analysis (qPCR) of control (U) and Sf3b4MO-injected embryos. Values are normalized to ef1α and presented as mean ± s.e.m.; (*) p < 0.002 (Student’s t-test), from five independent samples.
	Fig. 4. Sf3b4MO2, a splice blocking morpholino interferes with neural crest formation. (A) The PCR primers to analyze sf3b4 pre-mRNA splicing are indicated (green arrows). The splice blocking morpholino (Sf3b4MO2) targets intron2/exon3 junction (red bar). (B) In Sf3b4MO2-injected embryos a shorter Sf3b4 transcript is detected (red arrow) due to loss of exon 3. (C) At neurula stage the expression of snail2 and sox10 is reduced (arrows) in Sf3b4MO2-injected embryos (30 ng), while sox2 expression is broadened (brackets). Dorsal views, anterior to top. The injected side (right) is indicated by the lineage tracer (Red-Gal). (D) The graph is a quantification of the results from four independent experiments. The number of embryos analyzed (n) is indicated on the top of each bar. (E) At tailbud stage tfap2a and sox10 expression is reduced in the pharyngeal arches (brackets). Lateral views.
	Fig. 5. Sf3b4 depletion results in increased cell-death in the ectoderm. (A)In situ hybridization of Sf3b4MO2-injected embryos (30 ng) at stage 15 showing loss of sox10 expression on the injected side (upper panels). Sf3b4MO2 injection significantly increases the number of TUNEL-positive cells (middle panels). Sf3b4MO2 injection does not affect the levels of cell proliferation as visualized by phosphohistone H3 (pHH3) immunostaining (lower panels). Dorsal views, anterior to top. The injected side (right) is indicated by the lineage tracer (Red-Gal; arrows). (B-C) Graph illustrating the quantification of the number of TUNEL-positive (B) and pHH3-positive (C) cells on the control (Cont) and injected sides in embryos that received unilateral injection of Sf3b4MO2 (20 ng or 30 ng as indicated). The number of embryos analyzed (n=) is indicated on the top of each graph. Values are presented as mean ± s.e.m.; (*) p-value <0.0001 (Student’s t-test).
	Fig. 6. Loss of Sox10 expression in Sf3b4-depleted embryos is rescued by human SF3B4. (A) Distribution of the 18 unique mutations in SF3B4 gene (*) that cause Nager syndrome (Bernier et al., 2012). Using site directed mutagenesis we generated two constructs that duplicate the human frameshift mutation in exon 2 (c.88delT) and a nonsense mutation in exon3 (c.625C>T). Domain structure of SF3B4/SAP49 (blue boxes) is indicated with the position of the RRMs (green boxes). The predicted translational effect of the two SF3B4 mutations used in this study is shown. The red bar indicates altered amino acid sequence. Modified from Bernier et al., 2012. (B) Western blot using lysate from embryos injected with 2 ng of Xsf3b4, HSF3B4, 88delT or 625C>T mRNAs. α-tubulin is shown as a loading control. 88delT mRNA is expected to generate a short product (~4.0 kDa) not recognized by Sf3b4 antibody. (C) Wild-type (WT) HSF3B4 restore sox10 expression in Sf3b4-depleted embryos, while the mutated mRNAs are unable to do so. Dorsal views, anterior to top. The injected side (right) is indicated by the lineage tracer (Red-Gal). (D) The graph is a quantification of the results from four independent experiments. The number of embryos analyzed (n) is indicated on the top of each bar. (E) Injections of Xsf3b4, HSF3B4 mRNAs and its mutated versions had no effect on sox10 expression. Dorsal views, anterior to top. The injected side (right) is indicated by the lineage tracer (Red-Gal). (F) The graph is a quantification of the results. The number of embryos analyzed (n) is indicated on the top of each bar.
	Fig. 7. Long-term consequences of Sf3b4 depletion on craniofacial structures formation. (A) Migration and contribution of the neural crest to cranial skeletal elements. The mandibular neural crest segment (1; yellow) contributes to Meckel’s (M), palatoquadrate (Q), and subocular (So) cartilages; the hyoid neural crest segment (2; blue) contributes to the ceratohyal (C) cartilages; the anterior (3; purple) and posterior (4; red) branchial neural crest segments contribute to the cartilages of the gills (G). Modified from Sadaghiani and Thiebaud, 1987 and Baltzinger et al., 2005. (B) By in situ hybridization sox9 is detected in the four streams of neural crest cells migrating towards the pharyngeal arches, the mandibular (ma), hyoid (hy), anterior branchial (ab) and posterior branchial (pb) segments. Lateral view, anterior to left. ey: eye; ov: otic vesicle. Modified from Lee and Saint-Jeannet, 2011. (C) Alcian blue-stained craniofacial skeletal elements from a stage 45 tadpole. Modified from O’Donnell et al., 2006. (D) At neurula stage the expression of sox10 is reduced in Sf3b4MO2-injected embryos. Dorsal views, anterior to top. The injected side (right) is indicated by the lineage tracer (Red-Gal). (E) The graph is a quantification of the results from seven independent experiments. The number of embryos analyzed (n) is indicated on the top of each bar. (F) Gross morphology of Sf3b4MO2 (5 ng) and CoMO (10 ng)-injected tadpoles. Dorsal views, anterior to top. (G) The graph is a quantification of the results from four independent experiments. The number of tadpoles analyzed (n) is indicated on the top of each bar. (*) Embryos injected with 10 ng Sf3b4MO2 did not survive to the tadpole stage. (H) Examples of flat-mounts of Alcian blue-stained skeletal elements from stage 45 tadpoles injected with Sf3b4MO2 (2 ng). Similar phenotypes were observed with 5 ng Sf3b4MO2. Injected side is on the right. (I) The graph is a quantification of the results from three independent experiments. The size of Meckel’s, ceratohyal and branchial cartilages of affected tadpoles was measured and compared to the same cartilage on the contralateral side to define the percentage reduction. Error bars indicate mean ± s.e.m. Sf3b4MO2 (2 ng), n=69 and Sf3b4MO2 (5 ng), n=38.
	Fig. 8. Non-canonical function of Sf3b4 in BMP signaling. (A) At neurula stage the expression of msx1 is unaffected in Sf3b4MO2-injected embryos (arrows), while sox10 expression is reduced in sibling embryos. Dorsal views, anterior to top. The injected side (right) is indicated by the lineage tracer (Red-Gal). (B) The graph is a quantification of the results from three independent experiments. The number of embryos analyzed (n) is indicated on the top of each bar. (C) Western blot using lysate from embryos injected bilaterally with HSF3B4 mRNA (1 ng) or Sf3B4MO2 (10 ng) alone or in combination with BMP4 mRNA (1 ng) to analyze the levels of phosphorylated and unphosphorylated Smad1/5/8 at stage 10. HSF3B4 and Sf3B4MO2 have no impact on BMP4-mediated Smad1/5/8 phosphorylation (p-Smad1/5/8) and do not affect the levels of unphosphorylated Smad1/5/8. (D) By in situ hybridization, sox2 expression in animal explants neuralized by the BMP antagonist Noggin is unaffected by injection of Xsf3b4 or HSF3B4 mRNA (1 ng each).
	Supplementary Fig S1: RT-PCR analysis of the pre-mRNA processing of Sox10, Snail2, Twist, Sox9 and Pax3 in control, CoMO- and Sf3b4MO2-injected embryos. Embryos were injected bilaterally at the 2-cell stage with 10ng of CoMO or Sf3b4MO2. Embryos were collected at stage 15 and analyzed by RT-PCR using primers designed to amplify the coding region of each gene. With the exception of Sox10 for which the normal transcripts are absent, there was no increase in transcripts size for any of the genes analyzed.
	sf3b4 (splicing factor 3b subunit 4) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 15, anterior view, dorsal up.
	sf3b4 (splicing factor 3b subunit 4) gene expression in Xenopus laevis embryo, assayed via in situ hybridization, NF stage 28, lateral view, anterior left, dorsal up.

An, The zebrafish sf3b1b460 mutant reveals differential requirements for the sf3b1 pre-mRNA processing gene during neural crest development. 2012, Pubmed

An, The zebrafish sf3b1b460 mutant reveals differential requirements for the sf3b1 pre-mRNA processing gene during neural crest development. 2012, Pubmed
Aoki, Sox10 regulates the development of neural crest-derived melanocytes in Xenopus. 2003, Pubmed , Xenbase
Aylsworth, Nager acrofacial dysostosis: male-to-male transmission in 2 families. 1991, Pubmed
Baltzinger, Hoxa2 knockdown in Xenopus results in hyoid to mandibular homeosis. 2005, Pubmed , Xenbase
Bernier, Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome. 2012, Pubmed
Berry, The expression pattern of thyroid hormone response genes in remodeling tadpole tissues defines distinct growth and resorption gene expression programs. 1998, Pubmed , Xenbase
Betancur, Assembling neural crest regulatory circuits into a gene regulatory network. 2010, Pubmed
Bonilla-Claudio, Bmp signaling regulates a dose-dependent transcriptional program to control facial skeletal development. 2012, Pubmed
Champion-Arnaud, The prespliceosome components SAP 49 and SAP 145 interact in a complex implicated in tethering U2 snRNP to the branch site. 1994, Pubmed
Chang, The nonsense-mediated decay RNA surveillance pathway. 2007, Pubmed
Chemke, Autosomal recessive inheritance of Nager acrofacial dysostosis. 1988, Pubmed
Chen, PRPF4 mutations cause autosomal dominant retinitis pigmentosa. 2014, Pubmed
Chin, How insights from cardiovascular developmental biology have impacted the care of infants and children with congenital heart disease. 2012, Pubmed
Czeschik, Clinical and mutation data in 12 patients with the clinical diagnosis of Nager syndrome. 2013, Pubmed
Dauwerse, Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. 2011, Pubmed
Dixon, Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. 2006, Pubmed
Dixon, Treacher Collins syndrome. 1996, Pubmed
Hall, Nager acrofacial dysostosis: autosomal dominant inheritance in mild to moderately affected mother and lethally affected phocomelic son. 1989, Pubmed
Harland, In situ hybridization: an improved whole-mount method for Xenopus embryos. 1991, Pubmed , Xenbase
Hensey, Programmed cell death during Xenopus development: a spatio-temporal analysis. 1998, Pubmed , Xenbase
Hong, The activity of Pax3 and Zic1 regulates three distinct cell fates at the neural plate border. 2007, Pubmed , Xenbase
Hutson, Model systems for the study of heart development and disease. Cardiac neural crest and conotruncal malformations. 2007, Pubmed
Jones, Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. 2008, Pubmed
Kennedy, Newly recognized autosomal recessive acrofacial dysostosis syndrome resembling Nager syndrome. 2004, Pubmed
Lee, Sox9 function in craniofacial development and disease. 2011, Pubmed , Xenbase
Lehalle, A review of craniofacial disorders caused by spliceosomal defects. 2015, Pubmed
Linder, Systemic splicing factor deficiency causes tissue-specific defects: a zebrafish model for retinitis pigmentosa. 2011, Pubmed
Lines, Haploinsufficiency of a spliceosomal GTPase encoded by EFTUD2 causes mandibulofacial dysostosis with microcephaly. 2012, Pubmed
Luo, Induction of neural crest in Xenopus by transcription factor AP2alpha. 2003, Pubmed , Xenbase
Lynch, Disrupted auto-regulation of the spliceosomal gene SNRPB causes cerebro-costo-mandibular syndrome. 2014, Pubmed
Mayor, Induction of the prospective neural crest of Xenopus. 1995, Pubmed , Xenbase
McDonald, Nager acrofacial dysostosis. 1993, Pubmed
Minoux, Molecular mechanisms of cranial neural crest cell migration and patterning in craniofacial development. 2010, Pubmed
Mizuseki, Xenopus Zic-related-1 and Sox-2, two factors induced by chordin, have distinct activities in the initiation of neural induction. 1998, Pubmed , Xenbase
NULL, Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. The Treacher Collins Syndrome Collaborative Group. 1996, Pubmed
Nishanian, Interaction of the BMPR-IA tumor suppressor with a developmentally relevant splicing factor. 2004, Pubmed
Nur, Possible autosomal recessive inheritance in an infant with acrofacial dysostosis similar to Nager syndrome. 2013, Pubmed
O'Donnell, Functional analysis of Sox8 during neural crest development in Xenopus. 2006, Pubmed , Xenbase
Passos-Bueno, Syndromes of the first and second pharyngeal arches: A review. 2009, Pubmed
Petit, Nager syndrome: confirmation of SF3B4 haploinsufficiency as the major cause. 2014, Pubmed
Pignatti, To BMP or not to BMP during vertebrate limb bud development. 2014, Pubmed
Sadaghiani, Neural crest development in the Xenopus laevis embryo, studied by interspecific transplantation and scanning electron microscopy. 1987, Pubmed , Xenbase
Saka, Spatial and temporal patterns of cell division during early Xenopus embryogenesis. 2001, Pubmed , Xenbase
Santagati, Cranial neural crest and the building of the vertebrate head. 2003, Pubmed
Schlieve, Temporomandibular joint replacement for ankylosis correction in Nager syndrome: case report and review of the literature. 2012, Pubmed
Slack, An interaction between dorsal and ventral regions of the marginal zone in early amphibian embryos. 1980, Pubmed , Xenbase
Spokony, The transcription factor Sox9 is required for cranial neural crest development in Xenopus. 2002, Pubmed , Xenbase
Stuhlmiller, Current perspectives of the signaling pathways directing neural crest induction. 2012, Pubmed , Xenbase
Suzuki, Xenopus msx1 mediates epidermal induction and neural inhibition by BMP4. 1997, Pubmed , Xenbase
Tanackovic, PRPF mutations are associated with generalized defects in spliceosome formation and pre-mRNA splicing in patients with retinitis pigmentosa. 2011, Pubmed
Trainor, Patterning the cranial neural crest: hindbrain segmentation and Hox gene plasticity. 2000, Pubmed
Trainor, Craniofacial birth defects: The role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention. 2010, Pubmed
Trainor, Facial dysostoses: Etiology, pathogenesis and management. 2013, Pubmed
Waggoner, Deletion of 1q in a patient with acrofacial dysostosis. 1999, Pubmed
Watanabe, Splicing factor 3b subunit 4 binds BMPR-IA and inhibits osteochondral cell differentiation. 2007, Pubmed
Wieczorek, Compound heterozygosity of low-frequency promoter deletions and rare loss-of-function mutations in TXNL4A causes Burn-McKeown syndrome. 2014, Pubmed
Wieczorek, Human facial dysostoses. 2013, Pubmed
Will, Spliceosome structure and function. 2011, Pubmed